Work

Darbepoetin alfa has a longer circulating half-life and greater in vivo potency than recombinant human erythropoietin

Year: 2003

Type: article

Source: Experimental Hematology

DOI: 10.1016/s0301-472x(03)00006-7

Authors: Joan C Egrie, Erik Dwyer, Jeffrey K Browne, Anna Hitz, Michele A Lykos

Institution: Amgen (United States)

Language: English

Topic: Erythropoietin and Anemia Treatment

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2169177790

FWCI: 16.55

Cites: 47

Cited by: 430

Related to: 10